Bausch & Lomb, Incorporated

Rochester, New York 14609

0 studies enrolling now · 25 studies all time

What they study most

Astigmatism, Bacterial Conjunctivitis, Cataract, Contact Lens Wear, Dry Eye, Healthy, Hyperemia, Inflammation, Keratoconus, Myopia, Pain, Presbyopia

Studies at this site

• Surface Refractive Index Shift of Kalifilcon A Compared With Dailies Total1 and Precision1 Lenses — Completed
• Orientation Characteristics of Daily Disposable Toric Contact Lenses — Completed
• Kalifilcon A Toric Compared to Commercially Available Lenses — Completed
• 1-Week Dispensing Evaluation of REVIVE™ Toric Soft Contact Lenses — Completed
• A Study to Evaluate the Product Feasibility of Two New Silicone Hydrogel Contact Lenses — Completed
• Evaluation of the Feasibility a New Silicone Hydrogel Contact Lens — Completed
• Study of A New Contact Lens Cleaning and Disinfecting Solution — Completed
• Evaluation of Two Daily Disposable Contact Lenses. — Completed
• A Study to Evaluate the Feasibility of a High Add Multi Focal Contact Lens — Completed
• A Study to Evaluate the Product Performance of a Low Add MultiFocal Soft Contact Lens — Completed
• A Study to Evaluate a Mid Add Multi-Focal Soft Contact Lens — Completed
• Mapracorat Ophthalmic Suspension, 3% for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery — Completed
• Mapracorat Ophthalmic Suspension, 3% for the Treatment of Ocular Inflammation Following Cataract Surgery — Stopped early
• Mapracorat Ophthalmic Suspension for the Treatment of Ocular Inflammation Following Cataract Surgery — Completed
• Mapracorat Ophthalmic Suspension, 3% for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery — Completed
• Tear Evaluation Between Habitual Contact Lens Wearers and Non Contact Lens Wearers — Stopped early
• Post Approval Study to Evaluate the Trulign™ Toric Posterior Chamber IOL — Completed
• Pharmacokinetics and Safety of Topical Administration of Brimonidine Tartrate Ophthalmic Solution 0.025%. — Completed
• Evaluation of a New Silicone Hydrogel Contact Lens — Completed
• Twelve Month Clinical Evaluation of KeraSoft IC Soft Contact Lenses — Stopped early
• Clinical and Microbial Efficacy of Besifloxacin Ophthalmic Suspension, 0.6% in the Treatment of Bacterial Conjunctivitis — Stopped early
• A Study to Evaluate the Product Feasibility of a New Silicone Hydrogel Contact Lens — Completed
• Product Feasibility of a New Silicone Hydrogel Contact Lens — Completed
• Efficacy of Besifloxacin Ophthalmic Suspension in the Treatment of Bacterial Conjunctivitis — Completed
• Concentration of Besifloxacin, Gatifloxacin, and Moxifloxacin in Human Conjunctiva After Topical Instillation — Completed